Acculi Labs is a deep tech startup that provides life growth and home care solutions. The company raised $1.5 million from Sabi Holding India in its new funding. The funding round saw the participation of several new and existing investors. The startup plans to use these fresh proceeds to enhance its platform, develop its conscious AI insight systems, and scale up operations, research, and infrastructure development.
The startup will mainly focus on enhancing its manpower and operational efficiency while strengthening its market presence in India. The company secured Rs 5 crore from PirE Ventures during its 2020 seed funding round. Acculi Labs offers a platform that provides home-based care available for patients. The startup has flagship products including Lyfas which enables easy and early diagnostics while monitoring early-stage asymptomatic patients. This helps the patients to find doctors and treat the disease at an early stage which reduces the future risks. The firm plans to introduce new services and increase its efficiency through this funding. This investment round highlights the trust of Sabi Holding India in Acculi Lab’s market potential and business model.
The Bengaluru company claimed to have expanded its services from a Cardiac health assessment system provider to several health solutions using Lyfas. The startup provides its services via online platforms and mobile applications. The platform claims to deliver detailed health reports of patients within three minutes. The application is capable of non-invasively capturing psychophysiological biomarkers. The company wants to change the home-based care for patients using its cutting-edge technology. This fresh capital will be used to enhance the performance capability of the platform and develop more innovative healthcare solutions.
The startup has developed another flagship product, Lyra that removes the gap between carbon and silicon life forms. The platform uses artificial intelligence and advanced technologies to provide a seamless user experience. The company recently launched the Lyfas Udyam initiative to provide a micro-entrepreneurial circular economy for startups and small entrepreneurs. The application is to help small businesses run and start their businesses by offering them finance and processes. The company will use a portion of this investment to strengthen its brand presence while expanding globally. The Acculi labs face competition from other deep tech companies in this segment, including AliveCor, Imperative Care, and MYCLNQ Health.
Conclusion:
Acculi Labs is an AI-powered deep tech startup that raised 1.5 million USD in its new funding round from Sabi Holding India Ltd. The company intends to use this amount to scale up its product infrastructure, enhance its platform, research, increase its workforce, product development, and advance its technology. The startup previously secured Rs 5 crore in its seed funding round from PriE Ventures. The Bengaluru startup aims to provide home-based care products and services to patients. The platform provides detailed healthcare reports to patients in three minutes. The key offerings of the startup include Lyfas which is a Cardiac health assessment system and Lyra which reduces the gap between silicon and carbon life forms.
